MiMedx Group (MDXG) Tops Q2 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. DOX
4. VRTX
5. CHKP
6. CRWD
7. ON
8. HNGE
9. INSP
10. SPY

Go back to MiMedx Group (MDXG) Tops Q2 EPS by 1c

MiMedx Announces Record Results for Second Quarter of 2015

July 30, 2015 7:30 AM EDT

MARIETTA, Ga., July 30, 2015 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the second quarter of 2015.

Second Quarter 2015 Highlights

Q2 2015  is 15th consecutive quarter of meeting or exceeding Company revenue guidance Q2 2015 revenue of $45.7 million increased 79% over Q2 2014... More